Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?

NCT01295567 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Disease
Ischemic Heart Disease

Interventions

DRUG: Dipyridamole
DRUG: placebo

Sponsor

Radboud University Medical Center